Intra-alveolar tissue factor pathway inhibitor is not sufficient to block tissue factor procoagulant activity
- 1 May 2008
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 294 (5), L874-L881
- https://doi.org/10.1152/ajplung.00372.2007
Abstract
The alveolar compartment in acute lung injury contains high levels of tissue factor (TF) procoagulant activity favoring fibrin deposition. We previously reported that the alveolar epithelium can release TF procoagulant activity in response to a proinflammatory stimulus. To test the hypothesis that the alveolar epithelium further modulates intra-alveolar fibrin deposition through secretion of an endogenous inhibitor to TF, tissue factor pathway inhibitor (TFPI), we measured TFPI levels in edema fluid (EF) from patients with acute respiratory distress syndrome. To determine whether the alveolar epithelium can release TFPI, both full-length TFPI and truncated TFPI were measured (ELISA) in pulmonary edema fluid from patients with acute respiratory distress syndrome (ARDS) and a control group of patients with hydrostatic pulmonary edema (HYDRO). TFPI protein was also measured in conditioned media (CM) and cell lysates (CL) from human alveolar epithelial cells (A549) after exposure to cytomix (TNF-α, IL-1β, IFN-γ). TFPI protein levels were higher in pulmonary edema fluid from patients with ARDS vs. HYDRO. TFPI protein was increased in CM and did not change in CL after cytomix treatment; TFPI mRNA levels (RT-PCR) did not change. Despite the high levels of TFPI, both the EF and CM retained significant TF procoagulant activity as measured by plasma recalcification time. The majority of intra-alveolar TFPI was in a truncated, inactive form, whereas the majority of TFPI released from cells was full length, suggesting different mechanisms of inactivation. In summary, the alveolar epithelium releases TFPI in response to an inflammatory stimulus but does not increase TFPI gene transcription or protein production. Levels of intra-alveolar TFPI in ARDS are not sufficient to block intra-alveolar TF procoagulant activity due to truncation and inactivation of intra-alveolar TFPI.This publication has 47 references indexed in Scilit:
- Novel Role of the Human Alveolar Epithelium in Regulating Intra-Alveolar CoagulationAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factorThorax, 2007
- A GPI‐anchored co‐receptor for tissue factor pathway inhibitor controls its intracellular trafficking and cell surface expressionJournal of Thrombosis and Haemostasis, 2006
- Blockade of tissue factor-factor X binding attenuates sepsis-induced respiratory and renal failureAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- Temporal changes in pulmonary expression of key procoagulant molecules in rabbits with endotoxin-induced acute lung injury: elevated expression levels of protease-activated receptorsThrombosis and Haemostasis, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Plasma Markers of Endothelial Dysfunction in Chronic Obstructive Pulmonary DiseaseClinical and Applied Thrombosis/hemostasis, 2001
- Matrix Metalloproteinases Cleave Tissue Factor Pathway Inhibitor: Effects on coagulationOnline Journal of Public Health Informatics, 2000
- The Acute Respiratory Distress SyndromeThe New England Journal of Medicine, 2000
- Tissue Factor Pathway Inhibitor (TFPI) Antigen Plasma Level in Patients with Interstitial Lung Disease Before and After Heparin AdministrationSeminars in Thrombosis and Hemostasis, 1997